Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortIV anti-TNF biologic for Crohn's and arthritis.Biologic injection for arthritis, IBD and psoriasis.
Body systemJoints & ImmunityJoints & Immunity
Drug classTNF inhibitorsTNF inhibitors
SupplyPrescription onlyPrescription only
Main usesCrohn's disease, Ulcerative colitis, Rheumatoid arthritis, Ankylosing spondylitis, PsoriasisRheumatoid and psoriatic arthritis, Ankylosing spondylitis, Crohn's disease and ulcerative colitis, Psoriasis, Hidradenitis suppurativa
How it worksBlocks a key inflammation signal.Mops up a key inflammation signal.
Starts working——
Half-life8–10 daysAbout 2 weeks
Typical adult dose5 mg/kg IV at weeks 0, 2 and 6, then every 8 weeks.40 mg under the skin every other week (some conditions start higher or go weekly).
FormsIV infusion, Subcutaneous penPre-filled pen, Pre-filled syringe
Common side effectsInfusion reactions, Headache, Upper respiratory infectionsInjection-site reactions, Upper respiratory infections, Headache
Serious side effectsSerious infections and TB, Lymphoma (rare), Liver injurySerious infections including TB reactivation, Lymphoma (rare), Demyelination, Heart failure worsening
Don't take if——
Alcohol——
PregnancyUse with cautionOften continued with planning; affects the baby's early live vaccines.Use with cautionOften continued into pregnancy for IBD; baby's live vaccines may be delayed.
Breastfeeding——
In use since19982002
Brand namesUnited States: Remicade, Inflectra, ZymfentraUnited Kingdom: Remicade, Remsima, InflectraIndia: Remicade, InfimabUnited States: Humira, Hadlima, Hyrimoz, YuflymaUnited Kingdom: Humira, Amgevita, Imraldi, YuflymaIndia: Exemptia, Adfrar
Legal status——
ATC codeL04AB02L04AB04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker